{{Rsnum
|rsid=8192675
|Gene=SLC2A2
|Chromosome=3
|position=171007094
|Orientation=minus
|GMAF=0.3926
|Gene_s=SLC2A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 50.4 | 39.8 | 9.7
| HCB | 63.5 | 32.1 | 4.4
| JPT | 51.3 | 44.2 | 4.4
| YRI | 4.8 | 33.3 | 61.9
| ASW | 7.0 | 52.6 | 40.4
| CHB | 63.5 | 32.1 | 4.4
| CHD | 57.8 | 37.6 | 4.6
| GIH | 52.5 | 38.6 | 8.9
| LWK | 2.7 | 30.9 | 66.4
| MEX | 39.7 | 50.0 | 10.3
| MKK | 12.2 | 41.7 | 46.2
| TSI | 47.1 | 43.1 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23341889
|Title=Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}